000 01398 a2200361 4500
005 20250517062434.0
264 0 _c20170119
008 201701s 0 0 spa d
022 _a2171-8695
024 7 _a10.7399/fh.2015.39.5.8381
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHernández-Arroyo, María Jesús
245 0 0 _a[Patient safety: prescription of drugs that prolong the QT interval].
_h[electronic resource]
260 _bFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
_cSep 2015
300 _a227-39 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCross-Sectional Studies
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
_xdiagnosis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLong QT Syndrome
_xchemically induced
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPatient Safety
650 0 4 _aPrevalence
650 0 4 _aSpain
_xepidemiology
700 1 _aDíaz-Madero, Alfonso
700 1 _aMenacho-Miguel, David
773 0 _tFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
_gvol. 39
_gno. 5
_gp. 227-39
856 4 0 _uhttps://doi.org/10.7399/fh.2015.39.5.8381
_zAvailable from publisher's website
999 _c25428475
_d25428475